Management Board 12th Meeting - Part 3, 1996
Documents from 05 February 1996 to 24 February 1997Identity Statement
Paper
Casar, Andreja
Context
Content and Structure
Draft minutes and documents relating to the 12th Management Board meeting (Part 3) held on 4 December 1996 at EMEA headquarters, London.
This file is arranged as follows:
Follow up to the twelfth meeting and ad hoc group on fee reform, 5 December 1996. Attached is a Table of Proposed Fees Payable to the EMEA and Table of decisions and follow up for the Twelfth Meeting of the Management Board, London, 4 December 1996, and Possible Agenda Items for the Thirteenth Meeting, 5 February 1996 (p. 4); Follow up to 12th Management Board, 20 December 1996; correspondences from A Broström to F Sauer, February 1997; Telefax message from C Backman to A Cuvillier, 20 December 1996, subject "Standard Contract"; Views of the Danish Delegation on the present and future fees (EMEA document; MB/057/96), 20 December 1996; Draft Minutes of the Eleventh Meeting of the Management Board, London, 25 September 1996; Decision on a Scale of Fees to be Paid by the EMEA to National Competent Authorities in 1995 and 1996, Extended to 1997 by decision of the Management Board of 4 December 1996; Statement on the Principles Governing the Partnership Between the National Competent Authorities and the European Agency for the Evaluation of Medicinal Products, Adopted by the Management Board on 4 December 1996, and annexes (EN, FR, DE, IT, DK, PT, FI, ES); Correspondence regarding corrections to the Spanish language copy of the Statement on the Principles Governing the Partnership Between the National Competent Authorities and the European Agency for the Evaluation of Medicinal Products, Adopted by the Management Board on 4 December 1996 (ES); Budget for 1997 Adopted by the Management Board in December 199 including, "Establishment Plan" for temporary posts (EN, FR, DE, ES, IT, PT, NL, EL, DK, SV, FI); Copy of the Second General Report on the Activities of the European Agency for the Evaluation of Medicinal Products, 1996, Adopted by the Management Board on 4 December 1996, including annexes; Report on the Performance Goals and Indicators of the EMEA, 6 December 1996, and related documents; Additional partial copy of Managing the Business of the Board, Note by the Chairman; Basis for Reimbursement of Expenses for Delegates and Experts Attending Meetings, Adopted by the Management Board on 4 December 1996; Draft Minutes of the Twelfth Meeting of the Management Board, London 4 December 1996, including attendance list (p. 5); Correspondence and report from the European Court of Auditors entitled Avis No. 5/96 de la Cour des comptes des Communautés européennes sur le projet de modification du règlement financier de l’Agence européenne pour l’évaluation des médicaments (AEEM) (Londres), 11-12 December, 1996. English edition of the Official Journal of the European Communities, Volume 39, 31 October 1996, "Information and Notices". Regarding the notice of Recruitment for the European Agency for the Evaluation of Medicinal Products (London).
management board; financial regulation; EMA activities; press release; corporate governance
Conditions of Access and Use
Danish, Dutch, English, Finnish, French, German, Greek, Italian, Portuguese, Spanish, Swedish
Electronic File, Textual
Allied Materials
Notes
This file is in the archival box EMA-010.
The page numbering in the abstract refers to the physical copy of the file.
The provided digitised copy includes OCR and conforms to the PDF/A standard.